Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: ESSENTIAL ACCESS HEALTH
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-28 to 2025-05-30
Current total value of award: $349327
Description: NICHD: R&D: OVAPRENE PHASE 1:  PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL